19 1 General Introduction 27. World Health Organisation. Global Tuberculosis Report 2021: TB and Diabetes [Internet]. Geneva: WHO; 2021 Oct. Available from: https://www.who.int/publications/digital/global-tuberculosisreport-2021/featured-topics/tb-diabetes 28. Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):e0175925. 29. Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019 Apr;7(4):e448–60. 30. Alebel A, Wondemagegn AT, Tesema C, Kibret GD, Wagnew F, Petrucka P, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019 Mar 13;19(1):254. 31. Szablewski L, Sulima A. The structural and functional changes of blood cells and molecular components in diabetes mellitus. Biological Chemistry [Internet]. 2017 Apr 1 [cited 2023 Oct 1];398(4):411–23. Available from: https://www.degruyter.com/document/doi/10.1515/hsz-20160196/html 32. Magee MJ, Salindri AD, Kyaw NTT, Auld SC, Haw JS, Umpierrez GE. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Current diabetes reports. 2018;18:1–10.
RkJQdWJsaXNoZXIy MTk4NDMw